Jesse L. Berry, MD, is Professor of Ophthalmology at the USC Roski Eye Institute and Chief of Ophthalmology and Director of Ocular Oncology at Children's Hospital Los Angeles, where she holds the A. Linn Murphree, MD Chair in Retinoblastoma and the Berle and Lucy Adams Chair in Cancer Research. She specializes in the management of ocular tumors, including retinoblastoma and uveal melanoma, and is internationally recognized for her research developing the aqueous humor as a liquid biopsy for retinoblastoma, work supported by the National Cancer Institute. Dr. Berry is the founder of Women in Ocular Oncology and currently serves as President of the International Society of Ocular Oncology. She earned her medical degree from Harvard Medical School and completed her ophthalmology residency at LAC+USC Medical Center and a fellowship in ocular oncology at Children's Hospital Los Angeles.
Jesse L. Berry, MD, discusses prospective data on aqueous humor liquid biopsy in retinoblastoma and explains how molecular markers from the aqueous are beginning to guide recurrence risk, treatment intensity, and the workup of otherwise diagnostically inaccessible intraocular lesions.
